EGFR and colorectal cancer: Inhibition of Endophilin A2 enhances chemosensitivity of colorectal cancer cells through downregulation of multidrug resistance protein (MDR1), by which the effects were mediated via the epidermal growth factor receptor (EGFR)/extracellular signal-regulated kinase (ERK)/activator protein (AP-1) pathway (58).